The impact of modifiable risk factors on the long-term outcomes of non-alcoholic fatty liver disease

被引:33
|
作者
Paik, James M. [1 ]
Deshpande, Rati [1 ]
Golabi, Pegah [1 ]
Younossi, Issah [2 ]
Henry, Linda [2 ]
Younossi, Zobair M. [1 ,3 ]
机构
[1] Inova Hlth Syst, Betty & Guy Beatty Ctr Integrated Res, Falls Church, VA USA
[2] Ctr Outcomes Res Liver Dis, Washington, DC USA
[3] Inova Fairfax Hosp, Dept Med, Ctr Liver Dis, Falls Church, VA USA
关键词
CARDIOVASCULAR HEALTH; NATIONAL-HEALTH; NATURAL-HISTORY; MORTALITY; EPIDEMIOLOGY; ACCURACY; ADULTS;
D O I
10.1111/apt.15580
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background Cardiovascular (CV) disease is the leading cause of mortality in patients with non-alcoholic fatty liver disease (NAFLD). The American Heart Association (AHA) developed 7 CV health metrics (poor, intermediate and ideal health) to improve CV health. Aim To assess population-attributable fractions (PAFs) of CV health metrics to all-cause and CV mortality among NAFLD patients Methods We included adults participants from National Health and Nutrition Examination Survey (NHANES 1988-1994) with clinical and mortality data. NAFLD was defined as the presence of hepatic steatosis on ultrasonography in the absence of other chronic liver diseases and excessive alcohol use. Results A total of 4040 adults with NAFLD and 7515 without were included. NAFLD had fewer ideal health metrics than non-NAFLD (age-standardised prevalence: 20% vs 10% for <= 1 ideal health metric; 5.1% vs 8.7% for >= 6, all P < .001). Following median follow-up of 19.2 years (IQR: 17.5-21.0 years), 1,136 NAFLD subjects (327 CV deaths) and 1600 non-NAFLD subjects (447 CV deaths) died. Increased number of ideal health metrics (all trend P < .0001) equalled lower risk for all-cause and CV mortality. If all NAFLD subjects achieved 7 ideal health metrics, 66% of all-cause deaths and 83% of CV deaths were preventable. Among NAFLD subjects, lack of glycaemic control (adjusted PAF = 28.3% all-cause; 38.1% CV) and hypertension (adjusted PAF of 23% all-cause; 52.8% CV) were the largest mortality contributors. Ideal physical activity level obtainment provided an adjusted PAF = 13.9% all-cause and 13.8% CV mortality. Conclusions Attainment of ideal CV health metrics provides protection against all-cause and CV deaths in NAFLD.
引用
收藏
页码:291 / 304
页数:14
相关论文
共 50 条
  • [1] MODIFIABLE CARDIOVASCULAR (CV) RISK FACTORS ARE ASSOCIATED WITH LONG-TERM OUTCOMES OF NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)
    Paik, James
    Deshpande, Rati
    Golabi, Pegah
    Younossi, Issah
    Henry, Linda
    Younossi, Zobair M.
    [J]. HEPATOLOGY, 2019, 70 : 456A - 456A
  • [2] Long-term outcomes of non-alcoholic fatty liver disease and the risk factors for mortality and hepatocellular carcinoma in a Japanese population
    Kogiso, Tomomi
    Sagawa, Takaomi
    Kodama, Kazuhisa
    Taniai, Makiko
    Hashimoto, Etsuko
    Tokushige, Katsutoshi
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2020, 35 (09) : 1579 - 1589
  • [3] Long-Term Outcomes of Diabetic Patients with Non-alcoholic Fatty Liver Disease (NAFLD)
    Golabi, Pegah
    Shahab, Omer
    Stepanova, Maria
    Sayiner, Mehmet
    Clement, Stephen C.
    Younossi, Zobair M.
    [J]. HEPATOLOGY, 2017, 66 : 1142A - 1143A
  • [4] Prognostic impact of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis-related liver fibrosis on postoperative long-term outcomes of breast cancer
    Yeoh, Hyunsu
    Jang, Siwon
    Cheun, Jong-Ho
    Kwon, Jin Ah
    Lee, Myoung Seok
    Oh, Bumjo
    Choi, In Sil
    Oh, Sohee
    Kim, Jongjin
    Park, Jeong Hwan
    Kim, Won
    Hwang, Ki-Tae
    [J]. CANCER RESEARCH, 2023, 83 (05)
  • [5] Natural history and long-term outcomes of the Newcastle non-alcoholic fatty liver disease cohort
    Gallacher, Jenny
    Day, Chris
    Mcpherson, Stuart
    Anstee, Quentin
    [J]. JOURNAL OF HEPATOLOGY, 2023, 78 : S603 - S604
  • [6] Non-alcoholic fatty liver disease with and without metabolic syndrome: Different long-term outcomes
    Karajamaki, Aki Juhani
    Bloigu, Risto
    Kauma, Heikki
    Kesaniemi, Y. Antero
    Koivurova, Olli-Pekka
    Perkiomaki, Juha
    Huikuri, Heikki
    Ukkola, Olavi
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2017, 66 : 55 - 63
  • [7] Impact of Non-Alcoholic Fatty Liver Disease on Long-Term Survival for Resected Intrahepatic Cholangiocarcinoma
    Clark, Clancy J.
    Ali, Shahzad M.
    Zaydfudim, Victor M.
    Kendrick, Michael L.
    Lombardo, Kaye M. Reid
    Donohue, John H.
    Farnell, Michael B.
    Nagorney, David M.
    Que, Florencia G.
    [J]. GASTROENTEROLOGY, 2012, 142 (05) : S1096 - S1096
  • [8] NAFLD SIMULATOR: AN INTERACTIVE SIMULATION TOOL FOR LONG-TERM OUTCOMES OF NON-ALCOHOLIC FATTY LIVER DISEASE
    Dalgic, Ozden
    Samur, Sumeyye
    Corey, Kathleen
    Bethea, Emily
    Chen, Wanyi
    Loomba, Rohit
    Chhatwal, Jagpreet
    [J]. MEDICAL DECISION MAKING, 2020, 40 (01) : E376 - E376
  • [9] Long term outcomes of non-alcoholic fatty liver disease (NAFLD) and metabolic associated fatty liver disease (MAFLD)
    Younossi, Zobair
    Paik, James
    Younossi, Issah
    Golabi, Pegah
    Harring, Michael
    Henry, Linda
    [J]. JOURNAL OF HEPATOLOGY, 2022, 77 : S155 - S156
  • [10] Cardiovascular Risk Factors in Non-Alcoholic Fatty Liver Disease
    Hagstrom, Hannes
    Nasr, Patrik
    Ekstedt, Mattias
    Hammar, Ulf
    Stal, Per
    Hultcrantz, Rolf W.
    Kechagias, Stergios
    [J]. HEPATOLOGY, 2018, 68 : 950A - 950A